“Metabolic Activation and Inactivation of Irinotecan When Combined With the Human Monoclonal Antibody Bevacizumab”. Journal of Analytical Oncology 2, no. 4 (December 28, 2013):  218–225. Accessed April 29, 2026. https://neoplasiaresearch.com/index.php/jao/article/view/89.